Parkinson's Disease Quality of Life (PDQUALIF) - food preparation eating independent 7 days scale

General Details:

Name:
Parkinson's Disease Quality of Life (PDQUALIF) - food preparation eating independent 7 days scale
Steward:
NINDS
Definition:
Rating scale for preparing and eating independently in the past 7 days as part of Parkinson's Disease Quality of Life (PDQUALIF) form
Registration Status:
Qualified

Permissible Values:

Value Type:
Value List
Unit of Measure:
Ids:
Value Code Name Code Code System Code Description
Everyday Everyday Everyday
5-6 Days 5-6 Days 5-6 Days
3-4 Days 3-4 Days 3-4 Days
1-2 days 1-2 days 1-2 days
Never Never Never

Designations:

Designation:
Parkinson's Disease Quality of Life (PDQUALIF) - food preparation eating independent 7 days scale
Tags:
Designation:
In the past 7 days, in food preparation or eating I am independent
Tags:
Question Text

Designations:

Definition:
Rating scale for preparing and eating independently in the past 7 days as part of Parkinson's Disease Quality of Life (PDQUALIF) form
Tags:

Reference Documents:

ID:
Title:
URI:
Provider Org:
Language Code:
Document:
PDQUALIF M. Welsh and the Parkinson Study Group(TM), 1996. Reprinted with permission, Mickie Welsh. Mickie Welsh and the Parkinson Study Group(TM) are the copyright holders for the PDQUALIF. Welsh M., McDermott M.P., et al. (2003). Development and testing of the Parkinson's Disease Quality of Life Scale (PDQUALIF). Mov Disord 18(6):637-645. Parkinson Study Group. (2002). A controlled trial of rasagiline in early Parkinson disease: the TEMPO study. Arch Neurol, 59:1937-1943. Holloway R.G., Shoulson I., Fahn S, et al. (2004). Pramipexole vs. Levodopa as initial treatment for Parkinson's disease: a 4-year randomized controlled trial. Arch Neurol, 61:1044-1053. Parkinson Study Group. (2005). A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study. Arch Neurol 62:241-248. Fahn S., Parkinson Study Group. (2005). Does levodopa slow or hasten the rate of progression of Parkinson's disease? J Neurol, 252(Suppl 4):IV37-IV42. Brown C.A., Cheng E.M., et al. (2009). SF-36 includes less Parkinson Disease (PD)-targeted content but is more responsive to change than two PD-targeted health-related quality of life measures. Qual Life Res, 18:1219-1237.

Identifiers:

Source:
NLM
Id:
swf9t8Z7mg0
Version:
3.1
Source:
NINDS
Id:
C17386
Version:
3
Source:
BRICS Variable Name
Id:
PDQUALIFFoodPrepEatIndep7DScl
Version: